Ambrose Alli University Ekpoma in its bid to reclaim its enviable position among the comity of institutions grounded in research and higher learning has received the approval of the National Agency For Food And Drug Administration And Control, NAFDAC, as well as the rights of Production and Patents of GLUCOZIL.
The drug is a natural produce discovered by Dr. Jonathan Emeka Emordi of the Department of Pharmacology, and Sub-Dean, of Basic Clinical Sciences, College of Medicine, Ambrose Alli University, Ekpoma. It is prepared for the treatment of Diabetes Mellitus.
GLUCOZIL is manufactured to cause a regeneration of the beta cells that have been destroyed. If the product is used for a very long period, it will not only manage diabetes but cure it completely.
Dr. Emordi also indicated that GLUCOZIL, which can be used for the management, treatment and cure of diabetes, has bonus clinical indications for the treatment of BPH, commonly known as Enlarged prostate.
“In my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided.
“The product is scientifically tested, right dose confirmed, safety proven in both humans and animals. It is also capable of flushing the human system. Simply put, it is a detoxifier. It has strong anti-oxidant and anti-inflammatory activities which makes it an immune booster”, he declared.
Commending Dr. Emordi, the Acting Vice Chancellor, Ambrose Alli University, Ekpoma, Prof. Asomwan Sonnie Adagbonyin, said the Management is happy with the feat achieved at the College of Medicine and the Department of Pharmacology.
According to him, “We are proud of the ranking of our scholars who are determined to excel, do us proud despite the various human and environmental challenges. Management is proud of Dr. Emordi and I enjoin other scholars to see his achievement as motivation for them to break new grounds and open new frontiers of knowledge and innovation for further progress of this university in the super highway of teaching, research and community service.”